Concepedia

Shruti Malu

SM

Statistics

Publications

19

Citations

4.6K

H-Index

14

Active since

2003

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Icahn School of Medicine at Mount Sinai

Dana-Farber Cancer Institute

Immunitas Therapeutics (United States)

Yale University

Shruti Malu is an author at The University of Texas MD Anderson Cancer Center specializing in cancer immunotherapy, oncology, and tumor immunology.

Publications per year

2003–2023

19

Publications

19

Loss of PTEN Promotes Resistance to T Cell–Mediated Immunotherapy

Weiyi Peng, Jie Qing Chen, Chengwen Liu et al. · Cancer Discovery · 2015 · 1.5K citations · Full text

Medicine, Immunology, Oncology +17

A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade

Livnat Jerby‐Arnon, Parin Shah, Michael S. Cuoco et al. · Cell · 2018 · 1.4K citations · Full text

Medicine, Cancer Biology, Oncology +12

Increased Tumor Glycolysis Characterizes Immune Resistance to Adoptive T Cell Therapy

Tina Cascone, Jodi A. McKenzie, Rina M. Mbofung et al. · Cell Metabolism · 2018 · 624 citations · Full text

Medicine, Cancer Biology, Oncology +14

Multimodal pooled Perturb-CITE-seq screens in patient models define mechanisms of cancer immune evasion

Chris J. Frangieh, Johannes C. Melms, Pratiksha I. Thakore et al. · Nature Genetics · 2021 · 270 citations · Full text

Medicine, Cancer Biology, Oncology +16

HSP90 inhibition enhances cancer immunotherapy by upregulating interferon response genes

Rina M. Mbofung, Jodi A. McKenzie, Shruti Malu et al. · Nature Communications · 2017 · 156 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 19